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Abstract
Background: Environmentally growing pathogens present an increasing threat for human health, wildlife and food
production. Treating the hosts with antibiotics or parasitic bacteriophages fail to eliminate diseases that grow also
in the outside-host environment. However, bacteriophages could be utilized to suppress the pathogen population
sizes in the outside-host environment in order to prevent disease outbreaks. Here, we introduce a novel
epidemiological model to assess how the phage infections of the bacterial pathogens affect epidemiological
dynamics of the environmentally growing pathogens. We assess whether the phage therapy in the outside-
host environment could be utilized as a biological control method against these diseases. We also consider
how phage-resistant competitors affect the outcome, a common problem in phage therapy. The models give
predictions for the scenarios where the outside-host phage therapy will work and where it will fail to control
the disease. Parameterization of the model is based on the fish columnaris disease that causes significant
economic losses to aquaculture worldwide. However, the model is also suitable for other environmentally
growing bacterial diseases.
Results: Transmission rates of the phage determine the success of infectious disease control, with high-
transmission phage enabling the recovery of the host population that would in the absence of the phage go
asymptotically extinct due to the disease. In the presence of outside-host bacterial competition between the
pathogen and phage-resistant strain, the trade-off between the pathogen infectivity and the phage resistance
determines phage therapy outcome from stable coexistence to local host extinction.
Conclusions: We propose that the success of phage therapy strongly depends on the underlying biology,
such as the strength of trade-off between the pathogen infectivity and the phage-resistance, as well as on
the rate that the phages infect the bacteria. Our results indicate that phage therapy can fail if there are
phage-resistant bacteria and the trade-off between pathogen infectivity and phage resistance does not
completely inhibit the pathogen infectivity. Also, the rate that the phages infect the bacteria should be
sufficiently high for phage-therapy to succeed.
Keywords: Bacteriophage, Columnaris disease, Environmental opportunist, Flavobacterium, Host-parasite
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Background
Attempts to eliminate infectious diseases with antibiotics
are in many cases challenging, especially concerning
pathogens that are not solely dependent on the host for
growth but also replicate independently of the host in
the outside-host environment e.g. as saprotrophs. These
pathogens can be referred to as environmentally growing
opportunists [1–4]. Environmentally growing opportun-
ist pathogens are abundant and cause increasing eco-
nomical and health issues among both humans and
cultivated species. Pathogens that fall under this category
include for instance Vibrio cholera, Pseudomonas aerugi-
nosa, Legionella pneumophila, Listeria monocytogenes,
Cryptococcus neoformans and many species from genus
Mycobacterium, Flavobacterium and Serratia [1, 3, 5–15].
Antibiotics may fail to eradicate the entire pathogen
population even though all the infected hosts would be
successfully treated, as the pathogen population is cap-
able of surviving and growing independently of the hosts
in the environment [4]. New disease outbreaks can thus
occur even at a relatively short time period after con-
ducting antibiotic treatments, as has been seen in the
cases of cholera in humans [10] and the columnaris dis-
ease in cultivated freshwater fishes [13, 16, 17]. Attempts
to vaccinate the host also may be problematic because
immune allocation against a hypothetical pathogen may
render host vulnerable to other pathogens or parasites
[18]. Therefore, targeting solely the pathogen population
potentially growing inside the hosts may not be a suc-
cessful solution to disease control in the long run. Re-
garding fish diseases the antibiotic treatments have been
challenging as the treatment is usually conducted by ad-
ministering antibiotics in food mixtures and in many
cases, such as in columnaris disease, the infected fish
cease feeding [17, 19]. This increases the antibiotic resi-
dues that easily spread from the cultivation facilities to
the environment from the water circulation system in
fisheries and facilitate the evolution of multi-drug resist-
ant bacterial strains [19]. Extensive use of antibiotics has
promoted the spread of antibiotic resistance among the
pathogenic bacteria. Furthermore, leakages of antibiotics
to the environment cause disruption of the environmen-
tal microbial communities [19–21]. Disruption of the
microbial communities can decrease microbial competi-
tion and therefore promote invasions of novel diseases
and disease outbreaks [22, 23].
Phage therapy by bacteriophages has been considered
as an alternative method to antibiotics in controlling in-
fectious bacterial diseases [24]. Here, the interest is in
therapies using lytic bacteriophages that infect the bac-
teria cell and break them down by lysis [25]. In many
cases, including the columnaris disease, the phages are
rather strain-specific and thus, contrary to antibiotics,
they target primarily the intended bacterial disease agent
and do not harm other bacteria strains [19, 26]. Phage
therapy experiments have given both promising out-
comes as well as failed to eliminate the disease. Experi-
mental in vivo treatment of catfish infected by
columnaris disease agent F. columnare by oral introduc-
tion of phages has been successful [27]. However, phage
therapy has mostly considered the treatment of the hosts
in vivo and not targeting the pathogen population in the
outside-host environment [19, 28]. Another concern in
phage therapy is the existing or rapid development of re-
sistance against the bacteriophages [19, 24]. Methods for
local elimination of the environmentally growing oppor-
tunist disease by targeting the pathogen population in
the outside-host environment are needed to successfully
prevent disease outbreaks. The idea of using phages to
suppress the pathogen population in the outside-host
environment for disease prevention was introduced by
Levin and Bull already a decade ago [24]. They also
raised the issue of phage-resistance and introduced pre-
liminary phage-therapy models [24]. There are few pre-
vious phage-therapy models targeting environmental
bacterial population [29, 30]. However, these models
do not consider the phage-resistant competitors.
Thus, phage-therapy theory omitting the possibility
for phage-resistance is not realistic in long-term bio-
logical control [19].
Here, we study phage therapy as a biological control
method against the environmentally growing infectious
diseases by targeting the outside-host pathogen popula-
tion. Parameterization of the model is based on the
columnaris disease caused by saprotrophic bacterium
Flavobacterium columnare, but the model can also be
applied to other environmentally growing opportunist
diseases. As columnaris disease causes severe infections
in fresh-water fisheries worldwide, killing often all the
fish in the infected tank in a matter of days [13, 17, 31],
we chose pathogen-host parameters that would cause
the fast death of the whole susceptible host population
in the absence of the phage. We first analyze how intro-
ducing the phages into the host-pathogen system could
eliminate the disease and how good at infecting the bac-
teria the phage should be in order to accomplish this.
Secondly, we address the issue of resistance towards the
phages by considering different trade-off scenarios be-
tween the pathogen infectivity and the resistance to-
wards phages. We consider a scenario, where resistance
towards the phages is associated with complete or partial
loss of the pathogen infectivity.
Methods
The general model of phage therapy
We consider a deterministic continuous time model
combining the environmentally growing opportunist bac-
terial pathogen-host interaction and the outside-host
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pathogen-bacteriophage interaction. The model combines
SI dynamics based on model by Anderson and May
(1981) [32] with the pathogen outside-host growth model
[4] and the lytic viral infection by the bacteriophages to
describe changes in time (t) in the densities of the suscep-
tible hosts (S), the infected hosts (I), the pathogens (P), the
phage-resistant bacteria (B) and the pathogen bacterio-
phages (F) in the environment outside-host.
The complete model of phage therapy is given as
follows:
dS
dt
¼ rS 1−Sð ÞS−βSP−βBSB−μSIS þ δI þ δIB ð1Þ
dI
dt
¼ βSP− αþ μSIð ÞI−δI ð2Þ
dIB
dt
¼ βBSB− αþ μSIð ÞIB−δIB ð3Þ
dP
dt
¼ ΛαI þ rP 1− P þ Bð Þ=K½ P−μPP−βFPF ð4Þ
dB
dt
¼ ΛBαIB þ rB 1− P þ Bð Þ=K½ B−μBB ð5Þ
dF
dt
¼ ΛFβFPF−μF F ð6Þ
The logistic density-dependent growth of the suscep-
tible host (S, eq. 1) is determined by the growth rate rS
and the host carrying capacity, which is scaled to 1. Sus-
ceptible host population die at rate μSI. This death rate
represents mortality of the host through, e.g. predation,
which is the main proximate cause of mortality in fishes
in nature [33], or due to removal from the environment
by harvesting. The susceptible host population is also
suppressed as they are infected through environmental
transmission of the pathogen at rates β and βB. The sus-
ceptible hosts can recover from the disease at rate δ.
The infected host population size (I, eq. 2) increases
through environmental transmission rate β of the patho-
gens to the susceptible hosts depending on population
sizes of S and P. We omitted direct transmission of the
disease between hosts as columnaris disease is mainly
transmitted via the environment and direct transmission
of the disease is considered to be rare. We assume no re-
source competition between susceptible and infected
hosts as diseased animals generally cease feeding, which
is also the case regarding the fish infected by columnaris
disease [17, 19]. Furthermore, the infected hosts are not
able to reproduce once they have become infected and
cease feeding, as is the case with columnaris infections.
[17]. The infected hosts die due to the same causes as
the susceptible hosts (μSI) or due to the infection at a
rate α (indicating virulence). The infected hosts recover
from the disease at rate δ.
We also consider the situation where the phage-resistant
bacteria are also able to transfer to the susceptible
hosts at rate βB, which determines the increase of
the phage-resistant infected host population size (IB,
eq. 3) depending on population sizes of S and B. In
these situations, the phage-resistant infected hosts
die due to the disease (α) or due to the same causes
as the susceptible hosts (μSI).
The pathogen population in the outside-host environ-
ment (P, eq. 4) increases through the growth outside and
inside the hosts. The infected hosts that die due to the
disease at rate α and release new pathogens at rate Λ.
The pathogen release rate Λ reflects the overall growth
of the pathogen on the host through single infection in-
dependent of the infection time, as these pathogens are
able to grow in a dead host; in columnaris disease, the
release rate from the living hosts is minor as compared
to release rate from the dead hosts [13]. Novel patho-
gens are only released from the infected hosts as they
die to the infection and not when they die of other
reasons (μSI), indicating here mortality of the host
due to predation or harvesting because this would be
a dead-end for an ectoparasitic F. columnare [31].
The outside-host growth of the pathogen in eq. 4 is
density-dependent, determined by the maximum
growth rate rP and the constant parameter K modify-
ing the strength of density-dependence of the envir-
onmental growth rate. The pathogen P and the
phage-resistant non-pathogenic bacteria B compete
for the same resources in the environment. The
pathogen population dies at rate μP, describing e.g.
protozoa predation, and due to infection by the bacte-
riophages at rate βF, which also describes the trans-
mission rate of the bacteriophage to pathogenic
bacteria. For simplicity, we assume that the lysis of
the infected bacteria cells is instantaneous.
The phage-resistant bacteria population (B, eq. 5) in-
creases through the density dependent saprotrophic
growth in the environment with the growth rate rB,
which is influenced by the parameter K modifying the
strength of density-dependence of the environmental
growth rate. We omitted the mutation from pathogen to
phage-resistant from the model as trivial because selec-
tion sustains a steady phenotypic heterogeneity of mi-
crobes in the environment and thus the availability of
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these resistant strains in the environment can be as-
sumed [34–36].
Gaining resistance to the bacteriophages can result in
a total loss of the pathogen infectivity, as has been seen
in highly virulent F. columnare strains B67, B185 and
B245 [37]. However, phage resistance in F. columnare
does not necessarily mean a total loss of infectivity, even
though there is a trade-off between the pathogen infect-
ivity and the phage resistance. For instance, F. colum-
nare strain (Os06) has been observed to cause infections
at a low level even after development of phage resistance
[37]. In the model, we thus allow in some scenarios the
phage-resistant bacteria to increase inside the host at the
rate ΛB, when the infected hosts die at rate α. In the
analysis of the model we also consider an option where
phage resistance results in a complete loss of the patho-
gen infectivity. The phage-resistant bacteria die at rate
μB.
The phage infection (F, eq. 6) leads to immediate lysis
of the bacterial cell and production of phages, which are
released from the infected pathogen cells at rate ΛF, and
depending on the transmission rate βF. The phage popu-
lation size decay at rate μF.
Parameterization of the model
The parameter values used in the stability analyses were
selected to represent a large range of plausible biological
values for environmentally growing opportunist patho-
gens and their potential hosts, especially regarding the
columnaris disease. The parameter values used are given
in Table 1. The parameter values were chosen to present
a disease dynamics, where the pathogen drives the host
towards extinction in the absence of viral infection by
the bacteriophages (Additional file 1: Figure S1).
The growth rate of S (rS) corresponds the growth rate
of the multicellular hosts of the environmentally growing
opportunistic pathogen bacteria F. columnare [4]. The
outside-host growth rate of P and B (rB and rP) were set
to correspond to the growth rate of the environmental
bacteria and the environmentally growing pathogens,
such as F. columnare and S. marcescens [4, 38–40]. The
constant parameter K modifying the strength of
density-dependence of the environmental growth rate
was set to correspond the bacteria population densities
seen in the environment [38]. The growth of the patho-
gens inside the host (Λ and ΛB, indicating release rate of
new pathogens from infected hosts) was set to present
realistic pathogen shedding rates from a fish infected
with the columnaris disease [13]. The phage burst size
from an infected pathogen cell (ΛF) corresponds the ob-
served phage burst size per bacteria cell in experimental
studies [41–43]. The burst size can however vary quite a
lot, for instance in T4 bacteriophage burst size depends
strongly on the age of the bacteria cell culture [43].
Infectivity of the pathogen (β, transmission rate to
susceptible host) was set relatively low because in the
environmentally growing opportunist pathogens the
infectivity is generally assumed to be lower than in the
obligate pathogens, with the exception of immunocom-
promised hosts [44].
The phage-resistant pathogen infectivity (βB, transmis-
sion rate to susceptible host) was varied on lower levels
than β. This is due to the trade-off between the phage
resistance and infectivity, and because the F. columnare
strain is known remain phage-resistant while transform-
ing back to the infective type has low infectivity [37].
The phage transmission rate to the pathogens (βF) was
varied to explore how good at infecting the pathogens
the phage needs to be to accomplish the elimination of
the disease.
Virulence (α), indicating here the death rate of the in-
fected hosts to the disease, was set to present realistic mor-
tality to the infection by columnaris disease [4, 13, 17].
Here, we are considering a situation where the disease will
cause the extinction of the hosts in the absence of disease
control thus exceeding mortality due to e.g. harvesting or
predation. This can be the case for instance when consider-
ing columnaris disease epidemics in fish farms, where the
infection can kill the whole fish tank [13, 17]. This is why
we have set the background mortality of the hosts (μSI)
lower than α. The pathogen and the phage-resistant bac-
teria mortality (μP and μB) corresponds the observed death
rate in the aquatic bacteria [45, 46]. The phage decay rate
(μF) corresponds to those reported in previous studies [47,
48]. Finally, we assume in our main analyses that there is
no recovery from the infection as columnaris disease is
often lethal [13]. We however analyze separately how the
recovery of the hosts would affect the disease dynamics
under the situation where the phage-resistant strains are
non-pathogenic by varying it under realistic values.
Analysis
We analyzed the long-term ecological dynamics of our
phage-therapy models analytically and numerically. We fo-
cused on three major model assumptions: First, we assume
that there are no phage-resistant competitors of the patho-
gen present. This analysis highlights how the presence of a
bacteriophage infecting the bacteria at different rates affects
the environmentally growing disease dynamics (S-I-P) by
decreasing the pathogen population density. Second, we
consider how effective the phage therapy is in the presence
of phage-resistant competitors, when phage-resistance
comes at the cost of losing the pathogen infectivity com-
pletely. Third, we decrease the strength of the trade-off be-
tween phage resistance and infectivity, i.e. by assuming that
some degree of infectivity is possible among phage-resistant
competitors. When the phage-resistant competitors were
absent, the stability analysis of the positive equilibrium S, I,
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P, F > 0 was carried out by varying the phage transmission
rate (βF) and the phage burst size (ΛF) simultaneously.
Bifurcation analyses were obtained by simulating the
corresponding differential equation model until the dy-
namics were stabilized, that is, the initial transient was
removed. These attractors were presented in the figures
for the stable equilibria or stable periodic solutions.
Stable equilibria were also calculated analytically. The
bifurcation parameter is presented on the x-axis. Local
stability properties of the equilibria were studied by
calculating numerically the eigenvalues of the corre-
sponding Jacobian matrices (Additional file 2).
The disease dynamics were also analyzed numerically
using non-equilibrium initial densities for the pathogen,
Table 1 Parameter values used in the analyses
Parameter Explanation of the parameter Parameter values
α Virulence (Mortality of the infected hosts due to infection) 0.1 (day−1) in all the analysis
β Pathogen transmission rate to susceptible hosts from
environment
10−5
(day−1)
in all the analysis
Λ Pathogen release rate from infected hosts when they die 109 in all the analysis
βB Phage-resistant pathogen transmission rate to susceptible
hosts from environment
0–10−10
(day− 1)
in Fig. 3
0 (day− 1) in Figs. 1, 2; Additional file 1: Figure S1; Additional file 3:
Figure S2 and Additional file 4: Figure S3
ΛB Phage-resistant pathogen release rate from infected hosts
when they die
105 in Fig. 3
0 in Figs. 1, 2; Additional file 1: Figure S1; Additional file 3:
Figure S2 and Additional file 4: Figure S3
βF Phage transmission rate to pathogens from the environment 10−8–10− 4
(day− 1)
in Fig. 1
10− 7 (day−
1)
in Fig. 2
10− 3 (day−
1)
in Fig. 3 and Additional file 4: Figure S3
0 in Additional file 1: Figure S1
10− 9–10− 5
(day− 1)
in Additional file 3: Figure S2
ΛF Phage burst size from infected pathogen 100 in Figs. 1, 2 and 3 and Additional file 4: Figure S3
0 in Additional file 1: Figure S1
0.0001–10 in Additional file 3: Figure S2
rS Susceptible host growth rate 0.1 (day
− 1) in all the analysis
rP Pathogen growth rate outside-host 3 (day
−1) in all the analysis
rB Phage-resistant bacteria growth rate outside-host 3 (day
−1) in Fig. 3
0 (day− 1) in Figs. 1, 2; Additional file 1: Figure S1; Additional file 3:
Figure S2 and Additional file 4: Figure S3
K Constant parameter K modifying the strength of density-
dependence of the environmental growth rate
109 in all the analysis
μSI Mortality of the susceptible and infected hosts due to other
reasons than infection
0.001
(day−1)
in all the analysis
μP Pathogen mortality outside-host 0.1 (day
−1) in all the analysis
μB Phage-resistant bacteria mortality outside-host 0.1 (day
−1) in Fig. 3
0 (day− 1) in Figs. 1, 2; Additional file 1: Figure S1; Additional file 3:
Figure S2 and Additional file 4: Figure S3
μF Phage decay rate outside-host 0.1 (day− 1) in Figs. 1, 2, 3; Additional file 3: Figure S2 and Additional
file 4: Figure S3
0 (day− 1) in Additional file 1: Figure S1
δ Recovery of the hosts from infection 0 (day− 1) Figs. 1, 3; Additional file 1: Figure S1; Additional file 3:
Figure S2 and Additional file 4: Figure S3
0–0.8
(day− 1)
in Fig. 2
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the phage, the phage-resistant and the host populations.
Simulation length of 350 days was sufficient to uncover
the long-term dynamics. Bifurcation diagrams were ob-
tained by scoring the minimum and maximum values of
the population fluctuations after removing the initial
transient phase. First, the phage transmission rate (βF)
was varied in the absence of phage-resistant competitors
in bifurcation diagrams, with 20 different evenly distrib-
uted values from the value range used. Second, the re-
covery rate of the hosts from the disease (δ) was varied
in the absence of phage-resistant competitors. Third, the
phage-resistant non-pathogen growth rate (rB) was var-
ied. Finally, the phage-resistant transmission rate to the
susceptible host (βB) was varied when phage resistance
did not result in the total loss of the pathogen infectivity.
The numerical simulations of the model were performed
with MATLAB v. 2016a ODE15s solver (Mathworks).
Results
In order to support a thorough analysis of the
host-pathogen-phage system we begin by commenting
two simple community models, namely two-bacteria
strain-phage system (P-B-F) and host-two pathogen sys-
tem (S-P-B).
Epidemiological dynamics in the absence of the host (P-B-F)
The two bacteria strains compete for the resources they
obtain from the environment. If the immunity to the
phage of the bacteria strain B has developed without any
effect on the growth rate or mortality then, in the ab-
sence of the phage, their coexistence dynamics would be
equal resulting in neutrally stable equilibrium, where the
equilibrium levels of the bacteria strains (P;B ) are not
defined uniquely. Introducing a phage in this system will
cause additional mortality to the bacteria strain P with-
out resistance towards phages. Thus, in the presence of
the phage, the bacteria strain B would gain a competitive
advantage and the non-resistant bacteria strain P would
be driven to extinction. On the other extreme, the im-
munity to the phage of the bacteria strain B develops
with a full cost of losing the ability to grow in the envir-
onment (rB = 0). In this case, the bacteria strain B would
become extinct and the equilibrium levels of the
non-resistant bacteria strain P and the phage would be
P ¼ μ FΛ Fβ F > 0, and F ¼
frP ½1−PK −μPg
β F
> 0.
Epidemiological dynamics in the absence of phage
We next consider the case where the two pathogens at-
tack the host in the absence of the phage. We confine
ourselves to a simplified but illustrative case where the
pathogen B is inferior competitor as compared to the
pathogen P. In particular, we refer to the case analyzed
below where the competitive dynamics of the pathogens
in the environment are equal but the pathogen P is more
efficient in multiplying within the host than the patho-
gen B (rP = rB, μP = μB, ΛP >ΛB and βP > βB. According
the well-known competitive exclusion principle, patho-
gen P outcompetes pathogen B unless the host is driven
into extinction. As a whole, the analysis of the competi-
tion of infective pathogens is challenging and compli-
cated (for a more thorough analysis of the competitive
pathogens, see references by Anttila et al. 2013 and
Merikanto et al. 2014 [22, 23]).
Epidemiological dynamics in the absence of phage-
resistant competitor
We first consider the community S-I-P-F, where the
competing pathogen is absent (B = 0). We note that due
to the environmental growth capacity the pathogen is al-
ways able to invade the system when alone or when the
host is present. Thus, the possible patterns of species co-
existence are 1) the pathogen alone (P > 0, S=I=F = 0), if
the pathogen drives the host population to extinct and
the phage is not introduced into the system; 2) the
pathogen and the host coexist (P, S, I > 0, F = 0), the
phage is not introduced into the system; 3) the patho-
gen, the host and the phage coexist (P, S, I, F > 0); 4) the
host alone, after the phage has eradicated the pathogen.
We next assume that the pathogen P eliminates the
host in the absence of disease control (Additional file 1:
Figure S1). In a community (P, S, I), the pathogen drives
the host extinct if rS−μSI−β
½rP−μP K
rP
< 0 , or β > ðrS−μSI ÞrP½rP−μP K
(see the Additional file 3). After eliminating the host, the
pathogen settles down on the level P ¼ ðrP−μPÞK=rP .
Interestingly, the ability of the pathogen to drive the host
extinct does not depend on the release rate. On the
other hand, when the phage is present the host is able to
recover when rS−βP−μSI > 0, or P < ðrS−μSIÞ=β (see the
Appendix, S2). Recalling that P ¼ μF=ΛFβF , the condi-
tion becomes βF > βμF/(rS − μSI)ΛF.
We ask weather introducing the bacteriophages into
the system allows the recovery of the host population.
The effect of introducing a phage into the system can be
divided into three areas of impact: 1) When the phage
transmission rate is low (βF < 10
− 7) the phage is unable
to rescue the host. The dynamics of the coexisting
pathogen and phage are stable while the susceptible and
infected hosts are absent due to the disease (Fig. 1). 2)
When the phage transmission rate increases, the patho-
gen abundance decreases such that host population is
able to survive. The susceptible host population size and
the number of diseased individuals increase (Fig. 1). At
the same time, the population size of the bacteriophage
increases. 3) Finally, when the phage transmission rate
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continues to increase the disease begins to be under
control and the susceptible host population size ap-
proaches its carrying capacity. The number of the in-
fected hosts increases abruptly, after which their number
decrease asymptotically towards zero (Fig. 1). Low levels
of pathogen remain, keeping the phage present.
The previous analysis of the effect of the phage trans-
mission rate can be repeated for the release rate ΛF of
the phage, as the effects are qualitatively similar. Local
stability analysis shows that the positive equilibria for S,
I, P, F > 0 exist and are locally stable when the phage
transmission and the release rates are both high enough.
On the other hand, the coexistence of all the populations
is not possible when the phage transmission and the re-
lease rates are both low (ΛF < 1 and βF < 10
− 6) or either
of them is low (βF close to 10
− 6 or less, or ΛF close to
two or less). In these cases, the susceptible hosts will die
out. The phage is unable to survive when both the phage
transmission and the release rate are very low (ΛF < 1
and βF < 10
− 6). The pathogen is able to remain in the
system regardless of the absence of the host due to its
ability to grow environmentally outside of the host
(Additional file 3: Figure S2). When both the phage
transmission and the release rates are high (βF = 10
− 3
and ΛF = 100), the pathogen population decrease close
to zero almost immediately and the decrease in the in-
fected host population occurs with a delay (Additional
file 4: Figure S3).
Joint effect of the recovery and the phage treatment
In the absence of the phage the pathogen stabilizes to its
environmental carrying capacity (≈109) after driving the
host extinct, irrespective of the infected host recovery
rate. Introducing the phage drives the pathogen popula-
tion to low level (P = 104). Increasing recovery rate δ in-
creases the density of the susceptible hosts. The density
of infected hosts is increased because the infection po-
tential of the pathogen increases and more susceptible
hosts are enter the infected population. Also, the density
of the phages is increased due to the increased growth
of the pathogen, which in turn allows increase of the
phage population when there are more pathogens to
infect by the phages. In more detail, low recovery rates
(δ < 0.2) increase the densities of the infected hosts and
phage, while the recovery rates above 0.2 decrease the
densities of the infected hosts, as they are turning back
as susceptible hosts faster, and phage, as lower amount
of pathogens are released to the environment from
Fig. 1 Bifurcation diagrams of the model dynamics in the absence of the phage-resistant bacteria population (B = 0), presenting equilibrium
values of the susceptible host (S), the infected hosts (I), the pathogen (P) and the bacteriophage (F) population densities for the phage
transmission rate, 10− 8<βF < 10− 4. The x-axis is log10 scale. When the phage transmission rate is low (βF < 10− 7), the susceptible and the infected
hosts go asymptotically extinct while there is a stable coexistence of the pathogen and the phage. When the phage transmission rate increases,
the pathogen population size decreases while the susceptible host population increases, close to their carrying capacity at higher phage
transmission rates. The number of the infected hosts abruptly increases as phage transmission increases, but decrease asymptotically towards
zero at higher phage transmission rates. The parameter values used are shown in Table 1. Pathogen level in the absence of the host and phage
is indicated by “◊”. The coexistence equilibria of the pathogen and the phage in the absence of the host are denoted by “o”. The equilibrium
solutions of all populations in the presence of the phage are denoted by “*”
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infected hosts limiting phage growth potential. Pathogen
population densities are not affected by the recovery rate
of the hosts (Fig. 2). Thus, the recovery helps the host to
survive when the phage is not extremely efficient.
Epidemiology in the presence of phage -resistant non-
pathogenic competitors
When a phage-resistant non-pathogenic competitor is
introduced into the system it does not affect the disease
dynamics or phage therapy. The phage drives the patho-
gen to a typical low level and the competitor then fills
up the resource niche. In this case, the lower the patho-
gen level is, the higher the competitor level becomes.
The competitor has no positive or negative role – it only
utilizes the resources left by the pathogen. Moreover,
these results are independent of the competitor’s growth
rate rB.
Epidemiology in the presence of competition with the
less pathogenic phage-resistant form
Next we present a scenario, where the phage resistance
of the competing pathogen is traded off with the ability
to infect the susceptible hosts but does not fully remove
infectivity. When the phage is absent then the less viru-
lent bacteria can still kill the host. Neither of the patho-
gen types receives any advantage from infections since
the host has now gone extinct, and consequently, the dy-
namics of the two pathogens are equal (rP = rB and μP = μB).
As a result, the coexistence dynamics of the two forms of
the pathogens are now neutrally stable making their relative
abundance arbitrary (Fig. 3).
When the phage is introduced into the system the
pathogen P will be driven to a low level and a small pro-
portion of the hosts are infected by this pathogen. Due
to pathogen resistance against the phage and the re-
duced competition, the pathogen B will increase close
the environmental carrying capacity. Increasing trans-
mission rate reduces the susceptible population size.
Also, increasing transmission rate first increases the
number of infected hosts. Reduced susceptible popula-
tion size makes the number of infected host to
decrease again.
Discussion
We have considered phage therapy targeting the
outside-host population of environmentally growing
pathogens. Our results show that phage therapy can in
certain situations be efficient in eliminating the disease
but may fail in others.
We first examined phage therapy in the absence of
phage-resistant competitors of the pathogen. Here, the
presence of a high-transmission phage successfully en-
able the recovery of the host population that would in
the absence of the phage go asymptotically extinct due
to the disease. Interestingly, an increase in the number
of infections is seen as phage transmission increases,
Fig. 2 Bifurcation diagrams of the model dynamics in the absence of the phage-resistant bacteria population (B = 0), presenting population
densities of the susceptible host (S), the infected hosts (I), the pathogen (P) and the bacteriophage (F) for the host recovery rate, 0 < δ < 0.8. When
the recovery of hosts is not possible, the host are extinct. Increasing the recovery of hosts, increases the host and phage population sizes as well
as the number of infections, while recovery rates above 0.2 decrease the number of infections and the population size of the phage. Pathogen
populations remain stable regardless of the recovery rate of the hosts. The parameter values used are shown in Table 1
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which results from improved growth potential of the
susceptible hosts as the pathogen is diminished by the
phage. Higher phage transmission rates decrease the
number of infections by improved depletion of patho-
gens in the outside host environment. The rate of host
recovery is faster when the phage transmission rate is
high as the phage is able to deplete the infective patho-
gen population more successfully. However, if the phage
has either low transmission or release rate the phage
therapy is not successful in preventing local host
extinction.
Few phage therapy models have been developed for
treating the populations of cholera both inside and outside
hosts [29, 30]. These models address phage-therapy simi-
larly as we do in our first scenario, where we assume that
there are no phage-resistant competitors present. Phage
therapy models without the presence of phage-resistant
strains are, however, often unrealistic in long-term treat-
ment as the spread of the phage resistance among the
bacteria is common and usually quite rapid [19].
Experimental studies have established that an extreme
trade-off between the pathogen infectivity e and the
phage resistance exists among virulent F. columnare
strains that are the main pathogens causing severe
columnaris infections [37]. For columnaris disease, the
lack of pathogen virulence is comparable to the lack of
infection ability as the pathogen is mainly released only
as the host dies to the disease. We thus considered a
situation where phage-resistant and non-resistant strains
compete in the environment. If the phage-resistant
competitor cannot cause infections, it does not affect
the disease dynamics and only utilizes the outside host
resources filling in the resource niche when the phage is
able to keep the pathogen densities low.
The trade-off between the pathogen infectivity and the
phage resistance is not always clear-cut such that it re-
sults in a complete loss of infectivity and death the
hosts. The Os06 strain of F. columnare is for instance
still able to cause infections at a low level even after de-
veloping phage resistance [37]. Thus, we also considered
an option where the phage resistance does not fully
inhibit the ability to infect the hosts even though the
ability to infect the hosts is lower than among the patho-
gens without the phage resistance. Under these assump-
tions, where the phage resistance reduces the infectivity
but does not completely inhibit the pathogen infectivity,
stable coexistence of the pathogen, the phage-resistant
pathogen, the phage, and the susceptible and infected
hosts is possible when the phage-resistant transmission
rate is low. Here, the pathogen population exists in a
very low density. Once the phage-resistant transmission
rate increases slightly the phage-resistant pathogens with
low infectivity drive the host asymptotically extinct.
When the hosts are extinct, the non-resistant pathogen
and the phage-resistant pathogen persist in a stable
coexistence in the outside-host environment. In this
situation, the phage therapy fails and other methods for
lowering the pathogen population sizes in the environment
should be considered. For instance, controlling the disease
by suppressing the pathogen populations outside-host
Fig. 3 Bifurcation diagrams of the model dynamics with a competing pathogenic phage-resistant bacteria population. The panels represent the
pathogen (P), the phage-resistant (B) the bacteriophage (F), susceptible host (S), the non-resistant infected hosts (I), the phage-resistant infected
hosts (IB), population densities for the phage-resistant transmission rate to the susceptible hosts, 0 < βB < 10
− 10. The x-axis is log10 scale. When
the phage is absent (o) the pathogens drive the host extinct. When the phage is introduced into the system (*) pathogen P is driven on a low
level. Now, the abundance of the pathogen B drives the disease dynamics. With increasing infectivity the host population size deceases. The
number of the diseases caused by pathogen P remains low due to the phage-control. The disease occurs still due to the increased abundance of
the pathogen B. However, the increased infectivity on βB ultimately drives the host population extinct. The parameter values used are shown in
Table 1
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by using protozoan predators could be a promising
alternative [49].
Allowing hosts to recover from the disease affects the
population densities of the susceptible and infected host,
and phage, but not the pathogen. Low recovery rates of
the host increase the population densities of susceptible
host as well as infected host and phage. The increase in
susceptible host population density as recovery is in-
creased under the low value range enables better infec-
tion potential for the pathogen, which is seen as
increased infections. This would increase the population
density of pathogen without the presence of the phage.
However, the phage population increases as pathogen
growth is improved. Higher recovery rates of the host
increase the population density of the susceptible host
even further but decrease the population densities of the
infected host and phage by reducing the pathogen popu-
lation growth.
Our analysis shows that the success of phage-therapy
in biological control of this disease class is highly vari-
able, depending on the parameterization of the model.
Thus, we argue that the knowledge of the biological sys-
tem is essential in order to predict the outcome for the
disease control by phage therapy in practice. It is also
hypothetically possible that a more efficient phage in in-
fecting pathogens could be inferior in competition with
a less infective phage, when it comes to other traits, such
as survival time in the outside-pathogen environment.
Using phage-therapy in controlling diseases affecting for
instance fish farms, continuous feed of phages to fish
tanks during the epidemic periods might be necessary in
assuring the success of phage-therapy.
It has been suggested that using phage cocktails with
multiple species of phage rather than single phage spe-
cies could be more efficient in lowering the bacterial
densities, as has been shown in the laboratory with V.
cholerae [50]. Using a single phage against the pathogen
population might not be efficient as the phages are ra-
ther strain-specific and the pathogen population might
consist of different pathogen strains, as is the case re-
garding columnaris disease in fish tanks [19, 26, 39]. The
success of phage therapy however depends on which
strains are present in the pathogen population.
Conclusions
Our model analyses have demonstrated that phage ther-
apy can fail if there are phage-resistant bacteria and the
trade-off between pathogen infectivity and phage resist-
ance does not completely inhibit the pathogen infectiv-
ity. Also, the transmission rate of the phages influences
the success of phage therapy. Thus, it is critical to assess
these factors to gain successful phage therapy in practice
by conducting experiments to determine what is the in-
fection ability and burs size of different phages when
affecting specific pathogen strains in relation to a disease
caused by an environmentally growing pathogen and
how the pathogen virulence is changed in response to
gaining phage resistance.
Additional files
Additional file 1: Figure S1 Time dynamics of pathogen, susceptible
and infected host dynamics (S-I-P) in the absence of viral infection by
bacteriophages and competition between the phage-resistant bacteria
and the pathogen. X-axis and y-axis show time in days and the population
density, respectively. Parameter values used are given in Table 1. In the
absence of bacteriophages and phage-resistant bacteria, the pathogen (P),
drives the susceptible host quickly extinct after which the infected host
population goes extinct as well and the pathogen population stabilizes to
grow saprothrophically in the absence of susceptible hosts. (TIF 2383 kb)
Additional file 2: Equilibrium population densities and the Jacobian
matrices for phage therapy model (1)–(6). Local stability analysis of the P-
S-I submodel at S=I = 0 in the absence of recovery. (DOCX 30 kb)
Additional file 3: Figure S2 Local stability analysis for susceptible host,
infected host, pathogen and bacteriophage dynamics (S-I-P-F) when the
phage transmission and release rate are varied (10− 9 < βF < 10− 5 and
0.0001 < ΛF < 10). The positive equilibrium S, I, P, F > 0 is locally stable for
high values of ΛF and βF (blue area). The coexistence equilibrium does
not exist for lower values of when ΛF and βF (yellow area). In this case S
and I become asymptotically extinct. Pathogen P always survives and
even coexists with the phage F in the absence of the host S. The
parameter values used are shown in Table 1. (TIF 2096 kb)
Additional file 4: Figure S3 Time dynamics of pathogen, susceptible,
infected host and bacteriophage dynamics (S-I-P-F) when the phage
transmission and release rate are high (βF = 10− 3 and ΛF = 100). X-axis
shows time in days and y-axis the population density. The pathogen
population decreases close to extinction almost immediately, while there
is a delay of approximately 47 days for the elimination of the disease and
more than 50 days for decrease of the phage population close to extinction.
The parameter values used are shown in Table 1. (TIF 2818 kb)
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